Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-6-16
pubmed:databankReference
pubmed:abstractText
Pharmacogenetics aims to maximize benefits and minimize risks of drug treatment. Our objectives were to examine the influence of common variants of hepatic metabolism and transporter genes on the lipid-lowering response to statin therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/ABCG2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/ATP-Binding Cassette Transporters, http://linkedlifedata.com/resource/pubmed/chemical/CYP3A5 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL, http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 CYP3A, http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 Enzyme System, http://linkedlifedata.com/resource/pubmed/chemical/Fluorobenzenes, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA..., http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Organic Anion Transporters, http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/SLCO1B1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Simvastatin, http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides, http://linkedlifedata.com/resource/pubmed/chemical/rosuvastatin
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1942-3268
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
276-85
pubmed:dateRevised
2011-8-4
pubmed:meshHeading
pubmed-meshheading:20207952-ATP-Binding Cassette Transporters, pubmed-meshheading:20207952-Aged, pubmed-meshheading:20207952-Cholesterol, LDL, pubmed-meshheading:20207952-Cytochrome P-450 CYP3A, pubmed-meshheading:20207952-Cytochrome P-450 Enzyme System, pubmed-meshheading:20207952-Female, pubmed-meshheading:20207952-Fluorobenzenes, pubmed-meshheading:20207952-Genotype, pubmed-meshheading:20207952-Humans, pubmed-meshheading:20207952-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:20207952-Male, pubmed-meshheading:20207952-Middle Aged, pubmed-meshheading:20207952-Myocardial Infarction, pubmed-meshheading:20207952-Neoplasm Proteins, pubmed-meshheading:20207952-Odds Ratio, pubmed-meshheading:20207952-Organic Anion Transporters, pubmed-meshheading:20207952-Polymorphism, Single Nucleotide, pubmed-meshheading:20207952-Pyrimidines, pubmed-meshheading:20207952-Regression Analysis, pubmed-meshheading:20207952-Simvastatin, pubmed-meshheading:20207952-Sulfonamides
pubmed:year
2010
pubmed:articleTitle
Hepatic metabolism and transporter gene variants enhance response to rosuvastatin in patients with acute myocardial infarction: the GEOSTAT-1 Study.
pubmed:affiliation
Division of Cardiovascular and Diabetes Research, Multidisciplinary Cardiovascular Research Centre, Leeds Institute of Genetics, Health and Therapeutics, University of Leeds, Leeds, United Kingdom.
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't